Tumour blood flow changes induced by application of electric pulses

Citation
G. Sersa et al., Tumour blood flow changes induced by application of electric pulses, EUR J CANC, 35(4), 1999, pp. 672-677
Citations number
36
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
35
Issue
4
Year of publication
1999
Pages
672 - 677
Database
ISI
SICI code
0959-8049(199904)35:4<672:TBFCIB>2.0.ZU;2-7
Abstract
The effect of electric pulses on tumour blood flow was investigated in the murine fibrosarcoma SA-1. After the application of short intense electric p ulses, relative tumour perfusion was measured using an (RbCl)-Rb-86 extract ion technique. A significant reduction of tumour perfusion (similar to 30% of control) was observed within 1 h following the application of eight elec tric pulses to the tumour. Thereafter, tumour blood flow slowly recovered, almost reaching the pretreatment level by 24 h. No change in perfusion was induced in the untreated contralateral normal leg muscle.. PL similar patte rn of blood flow reduction was induced when a second set of electric pulses was applied to the tumour following a 24 h interval. The degree of tumour blood flow reduction was dependent upon the number of electric pulses appli ed, at 1040 V, and less effect was observed if less than eight pulses were applied. A modification of the amplitude of the electric pulses resulted in changes in the direction of tumour blood flow response. Tumour blood flow increased following pulses in the range between 80 and 560 V and decreased at amplitudes higher than 640 V. These results demonstrate that the local a pplication of electric pulses to solid tumours can modify tumour blood flow . Pulses of increased amplitude resulted in the progressive reduction of tu mour blood flow with a corresponding increase in tumour cytotoxicity as mea sured by growth delay. Tumour blood flow reduction by electric pulses could have potential in exploiting modalities mediated by tumour hypoxia, e.g. a ctivation of bioreductive agents. (C) 1999 Elsevier Science Ltd. All rights reserved.